Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Aegis Sciences Corporation currently manages 1 pending office action in the Chemistry & Materials technology area. This workload is assigned to 1 distinct examiner and 1 distinct art unit, representing a highly centralized prosecution footprint. The involvement of only 1 examiner suggests that the company's current patent office activity is focused on a specific innovation within the chemical or materials science field.
The busiest examiner for this portfolio is FRITCHMAN, REBECCA M, who is responsible for 1 pending office action. Because the total number of pending office actions is 1, this examiner handles the company's entire active workload. This 1 to 1 ratio between the busiest examiner's load and the total pending actions indicates that the company's immediate prosecution progress in the Chemistry & Materials sector is tied to the feedback of FRITCHMAN, REBECCA M.
Practitioners should note that having 1 distinct art unit and 1 distinct examiner for the 1 pending office action allows for a very targeted response strategy. There is no need to coordinate across different examiners or units, as all current prosecution activity is contained within this single case. This streamlined profile simplifies the administrative requirements and provides a clear path for the applicant to address the outstanding office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FRITCHMAN, REBECCA M | 1 | 45.7% | +35.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18634737 | Chronic Disease Management Test to Inform Clinical Care of Patients with Chronic Conditions | FRITCHMAN, REBECCA M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18634737 | Chronic Disease Management Test to Inform Clinical Care of Patients with Chronic Conditions | FRITCHMAN, REBECCA M | — |
| Art Unit | Apps |
|---|---|
| 1758 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18634737 | Chronic Disease Management Test to Inform Clinical Care of Patients with Chronic Conditions | FRITCHMAN, REBECCA M | 1758 | §101§103 | Non-Final OA | — | Pending | Apr 12, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial